These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22342372)

  • 1. Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders.
    Virdee K; Cumming P; Caprioli D; Jupp B; Rominger A; Aigbirhio FI; Fryer TD; Riss PJ; Dalley JW
    Neurosci Biobehav Rev; 2012 Apr; 36(4):1188-216. PubMed ID: 22342372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress on the application of positron emission tomography imaging of cannabinoid type 1 receptor in neuropsychiatric diseases.
    Ma L; Wu S; Zhang K; Tian M; Zhang H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 50(5):666-673. PubMed ID: 34986538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiopharmaceuticals in neurological and psychiatric disorders.
    Valotassiou V; Wozniak G; Sifakis N; Demakopoulos N; Georgoulias P
    Curr Clin Pharmacol; 2008 May; 3(2):99-107. PubMed ID: 18690884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders.
    Verhoeff NP
    Psychopharmacology (Berl); 1999 Dec; 147(3):217-49. PubMed ID: 10639681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments on PET radiotracers for TSPO and their applications in neuroimaging.
    Zhang L; Hu K; Shao T; Hou L; Zhang S; Ye W; Josephson L; Meyer JH; Zhang MR; Vasdev N; Wang J; Xu H; Wang L; Liang SH
    Acta Pharm Sin B; 2021 Feb; 11(2):373-393. PubMed ID: 33643818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Rodent Brain Receptor Imaging.
    Herfert K; Mannheim JG; Kuebler L; Marciano S; Amend M; Parl C; Napieczynska H; Maier FM; Vega SC; Pichler BJ
    Mol Imaging Biol; 2020 Apr; 22(2):223-244. PubMed ID: 31168682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases.
    Cai Z; Li S; Matuskey D; Nabulsi N; Huang Y
    Neurosci Lett; 2019 Jan; 691():44-50. PubMed ID: 30075287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of synaptic density with [
    Xiong M; Roshanbin S; Rokka J; Schlein E; Ingelsson M; Sehlin D; Eriksson J; Syvänen S
    Neuroimage; 2021 Oct; 239():118302. PubMed ID: 34174391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging in neurology: Alzheimer's and Parkinson's diseases.
    Sarikaya I
    Nucl Med Commun; 2015 Aug; 36(8):775-81. PubMed ID: 25920047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET tracers for imaging of the dopaminergic system.
    Elsinga PH; Hatano K; Ishiwata K
    Curr Med Chem; 2006; 13(18):2139-53. PubMed ID: 16918344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positron emission tomography with FDG and newly developed tracers for the assessment of brain metabolism and synaptic function in neurological disorders].
    Momose T
    Brain Nerve; 2007 May; 59(5):495-501. PubMed ID: 17533975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain.
    Casteels C; Vermaelen P; Nuyts J; Van Der Linden A; Baekelandt V; Mortelmans L; Bormans G; Van Laere K
    J Nucl Med; 2006 Nov; 47(11):1858-66. PubMed ID: 17079820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET brain imaging in neurological disorders.
    Xie L; Zhao J; Li Y; Bai J
    Phys Life Rev; 2024 Jul; 49():100-111. PubMed ID: 38574584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundamentals of positron emission tomography and applications in preclinical drug development.
    Cherry SR
    J Clin Pharmacol; 2001 May; 41(5):482-91. PubMed ID: 11361044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
    Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropharmacological studies with SPECT in neuropsychiatric disorders.
    Heinz A; Jones DW; Raedler T; Coppola R; Knable MB; Weinberger DR
    Nucl Med Biol; 2000 Oct; 27(7):677-82. PubMed ID: 11091111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders.
    Hesse S; Barthel H; Schwarz J; Sabri O; Müller U
    Neurosci Biobehav Rev; 2004 Oct; 28(6):547-63. PubMed ID: 15527862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. News and views on in-vivo imaging of neurotransmission using PET and MRI.
    Sander CY; Hesse S
    Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):414-428. PubMed ID: 28750497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography imaging in neurological disorders.
    Politis M; Piccini P
    J Neurol; 2012 Sep; 259(9):1769-80. PubMed ID: 22297461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent and future evolutions in NeuroSPECT with particular emphasis on the synergistic use and fusion of imaging modalities.
    d'Asseler YM; Koole M; Lemahieu I; Achten E; Boon P; De Deyn PP; Dierckx RA
    Acta Neurol Belg; 1997 Sep; 97(3):154-62. PubMed ID: 9345586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.